San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, August 18, 2015 Link here. AmpliPhi Biosciences Corporation (OTCQB: APHBD), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced that its shares of common stock have been approved for listing on the NYSE MKT, subject to continued satisfaction of […]
– Digital health company’s technology proven to improve adherence and patient health in chronic respiratory disease – $25.85m in signed commitments, AstraZeneca US$3m cornerstone investment; led Bell Potter Securities – First-in-class 10 year Supply and Development Agreement with AstraZeneca – Technology has been used in 40 projects, across 29 countries, with 32 publications referencing Smartinhaler 5 August 2015 […]
Company Announces One-for-Fifty Reverse Stock Split Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on August 07, 2015 San Diego and Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, August 04, 2015 –Linkhere. AmpliPhi BioSciences Corporation (OTCQB: APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today […]
28 July 2015. Link here. SeaDragon Limited (NZX:SEA) today releases an update to the market detailing the company’s progress towards completing the Omega-3 production plant. The update also includes an overview of; • Key products • Customers • The rationale for investment in SeaDragon • The use of proceeds • Financial forecasts • Sustainability statement For […]
23 July 2015. Link here. First-in-class collaboration combining digital health with class leading inhaled medications Long term international supply agreement targeted at AstraZeneca’s patient support programs Adherium’s Smartinhaler proven to substantially improve medication adherence and health outcomes in adults and children New Zealand-based Adherium (NZ) Limited has entered a long term partnership with international pharmaceutical leader […]
22 July 2015 – link here. Letter from the CEO.
20 July 2015. Link here.
20 July 2015, link here. Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheel-chair users, is pleased to announce that it has today signed a new agreement for a partnership in China with MAAB Group, an investment and trading company that specialises in sourcing and introducing innovative […]
20 July 2015 – Link here.
DUBLIN, Ireland, July 7, 2015 (GLOBE NEWSWIRE) — Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the signing of a research and development agreement with leading Japanese animal health company Zenoaq (Nippon Zenyaku Kogyo Co., Ltd.) to develop a number of therapeutic biologics for companion animals. The biologics will target undisclosed proteins involved […]
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: